Cigna Group
CI
View Detailed Chart
276.830USD
+2.130+0.78%
Market hours （ET）Quotes delayed by 15 min
73.80BMarket Cap
12.16P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.78%
5 Days
+4.29%
1 Month
+2.66%
6 Months
-12.78%
Year to Date
+0.25%
1 Year
-1.78%
View Detailed Chart
TradingKey Stock Score of Cigna Group
Currency: USD Updated: 2025-12-12Key Insights
Cigna Group's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 3/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 329.04.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cigna Group's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
26
analysts
Buy
Current Rating
329.044
Target Price
+24.86%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cigna Group Highlights
StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 247.12B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Undervalued
The company’s latest PE is 12.06, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 242.25M shares, increasing 0.07% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 90.00 shares of this stock.
Cigna Group News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cigna Group Info
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Ticker SymbolCI
CompanyCigna Group
CEOCordani (David M)
Websitehttps://www.thecignagroup.com/
FAQs
What is the current price of Cigna Group (CI)?
The current price of Cigna Group (CI) is 276.830.
What is the symbol of Cigna Group?
The ticker symbol of Cigna Group is CI.
What is the 52-week high of Cigna Group?
The 52-week high of Cigna Group is 350.000.
What is the 52-week low of Cigna Group?
The 52-week low of Cigna Group is 239.510.
What is the market capitalization of Cigna Group?
The market capitalization of Cigna Group is 73.80B.
What is the net income of Cigna Group?
The net income of Cigna Group is 3.43B.
Is Cigna Group (CI) currently rated as Buy, Hold, or Sell?
According to analysts, Cigna Group (CI) has an overall rating of Buy, with a price target of 329.044.
What is the Earnings Per Share (EPS TTM) of Cigna Group (CI)?
The Earnings Per Share (EPS TTM) of Cigna Group (CI) is 22.771.
Related Instruments
-0.64%
+2.36%
-0.69%
+2.44%
-0.01%
-0.55%
-0.58%
-0.96%
-2.40%
+0.31%
+0.64%
+1.06%
-0.28%
-0.41%
+0.38%
+0.18%
+0.42%
-0.05%
+0.21%Popular Symbols
